Spt Life Sciences Announces Acquisition Of Lbd Life Sciences

Spt Life Sciences, A Global Group Of Innovative Technology Companies Focused On Supporting The Life Sciences Industry To Deliver More Effective Research, On 15 Sep 2020 Announced The Completion Of The Acquisition Of Lbd Life Sciences, A Leading Supplier Of Instrumentation To The Drug Discovery Market In China.Spt Life Sciences Backed By Technology-Focused Investment Firm Battery Ventures, Had Previously Held A Minority Stake In Lbd Life Sciences. This Latest Deal Sees The Purchase Of All Remaining Shares.As A Result Of This Acquisition Spt Life Sciences Extends Its Commercial Reach Into The Rapidly Growing Chinese Life Sciences Research Market. Lbd Life Sciences Will Join The Family Of Companies Including Spt Labtech Ltd And Quantifoil Who Together Will Be Better Placed To Meet The Rapidly Evolving Needs Of The Chinese Research Community.Patrick Bennett, Group Ceo Of Spt Labtech, Said, "We Are Delighted To Complete The Deal And We Are Very Excited To Bring Lbd Into The Group. This Investment Highlights Spt Life Sciences Commitment To Developing A Global Portfolio Of Companies With A Range Of Specialisms That Help Life Science Professionals World-Wide To Achieve Their Research Goals. For Over 10 Years The Team At Lbd Have Supported The Growing Life Science Research Community In China And We Believe That This Investment Will Ensure They Are Able To Do So Going Forward.&Rdquo;Sean Xiao, Managing Director Of Lbd Life Sciences Commented &Ldquo;As Part Of Spt Life Sciences We Will Remain Deeply Committed To Solving Asia&Rsquo;S Life Science Customers' Toughest Research Problems By Leveraging Our Expertise, And Enabling Access To Cutting Edge Instrumentation. We Can See Many Advantages Of Being Part Of The Group And Look Forward To The Future

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!